EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ADAM-10 Is Involved in Osteoblast Mineralization and Rheumatoid Arthritis-Associated Bone Destruction

Haruka Nakamura, Hiroyuki Kojima iD, Kohei Maeda iD, Kosuke Sakurai iD, Toshihiro Tanioka, Sho Ishii, Kuninobu Wakabayashi iD, Masahiro Hosonuma, Yuki Azetsu, Masayuki Iyoda iD, Masamichi Takami, Takeo Isozaki iD

International Journal of Molecular Sciences · 03.11.2026 · 27 (21) · 9842

DOI: 10.3390/ijms27219842 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.11.2026. Verfasst von Haruka Nakamura und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogenesis and Translational Medicine, Showa Medical University Graduate School of Pharmacy, Tokyo 142-8555, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Osteoblasts, ADAM10 Protein, Calcification, Physiologic. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA), a chronic autoimmune condition, causes irreversible bone destruction. A disintegrin and metalloprotease 10 (ADAM-10) has been implicated in inflammatory processes in RA. We investigated the potential role of ADAM-10 in osteoblast mineralization and RA-associated bone destruction. Serum ADAM-10 levels in RA patients were measured by ELISA, and ADAM-10 expression in osteoblasts was assessed by Western blotting. Collagen-induced arthritis (CIA) mice were treated intraperitoneally with the ADAM-10 inhibitor GI254023X (100 mg/kg) for three weeks. Arthritis and bone destruction were evaluated by macroscopic, immunohistochemical, histological, and micro-CT analyses. The effects of ADAM-10 inhibition on primary osteoblast mineralization were also assessed by Alizarin Red S staining. Serum ADAM-10 levels in patients with RA tended to be higher at Stage III of the Steinbrocker classification. In CIA mice, ADAM-10 inhibition attenuated weight loss, paw swelling, and arthritis scores and suppressed bone destruction. ADAM-10 inhibition also significantly reduced Rankl expression in knee joints. Furthermore, the inhibition reversed the suppression of primary osteoblast mineralization induced by TNF-α. Pharmacological inhibition of ADAM-10 attenuated experimental arthritis and bone destruction and improved osteoblast mineralization, suggesting that ADAM-10 may contribute to inflammatory bone destruction in RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidOsteoblastsADAM10 ProteinCalcification, PhysiologicAnimalsHumansMiceMaleArthritis, ExperimentalMice, Inbred DBARANK LigandTumor Necrosis Factor-alphaDipeptidesHydroxamic AcidsMembrane ProteinsAmyloid Precursor Protein Secretases

Stichwörter der Autor:innen

ADAM-10CIARA-HOBbone destructioninflammationprimary osteoblastrheumatoid arthritis

Substanzen

ADAM10 ProteinADAM10 protein, humanAdam10 protein, mouseRANK LigandTumor Necrosis Factor-alpha3-(formylhydroxyamino)-2-(3-phenyl-1-propyl)butanoic acid (2,2-dimethyl-1-methylcarbamoyl-1-propyl)amideDipeptidesHydroxamic AcidsMembrane ProteinsAmyloid Precursor Protein Secretases

Autor:innen und Institutionen

  • Department of Pathogenesis and Translational Medicine, Showa Medical University Graduate School of Pharmacy, Tokyo 142-8555, Japan.
  • Division of Rheumatology, Department of Medicine, Showa Medical University, Tokyo 142-8555, Japan.
  • Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo 142-8555, Japan.
  • Pharmacological Research Center, Showa Medical University, Tokyo 142-8555, Japan.
  • Department of Pharmacology, Graduate School of Dentistry, Showa Medical University, Tokyo 142-8555, Japan.
  • Department of Microbiology and Immunology, Showa Medical University Graduate School of Medicine, Tokyo 142-8555, Japan.

ORCID-Profile: Hiroyuki Kojima, Kohei Maeda, Kosuke Sakurai, Kuninobu Wakabayashi, Masayuki Iyoda, Takeo Isozaki

Zitieren

APA

Nakamura, H., Kojima, H., Maeda, K., Sakurai, K., Tanioka, T., Ishii, S., Wakabayashi, K., Hosonuma, M., Azetsu, Y., Iyoda, M., Takami, M., & Isozaki, T. (2026). ADAM-10 Is Involved in Osteoblast Mineralization and Rheumatoid Arthritis-Associated Bone Destruction. International Journal of Molecular Sciences, 27(21), 9842. https://doi.org/10.3390/ijms27219842

Vancouver

Nakamura H, Kojima H, Maeda K, Sakurai K, Tanioka T, Ishii S, et al. ADAM-10 Is Involved in Osteoblast Mineralization and Rheumatoid Arthritis-Associated Bone Destruction. International Journal of Molecular Sciences. 2026;27(21):9842. doi:10.3390/ijms27219842

BibTeX
@article{Nakamura2026,
  author = {Nakamura, Haruka and Kojima, Hiroyuki and Maeda, Kohei and Sakurai, Kosuke and Tanioka, Toshihiro and Ishii, Sho and Wakabayashi, Kuninobu and Hosonuma, Masahiro and Azetsu, Yuki and Iyoda, Masayuki and Takami, Masamichi and Isozaki, Takeo},
  title = {ADAM-10 Is Involved in Osteoblast Mineralization and Rheumatoid Arthritis-Associated Bone Destruction},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9842},
  doi = {10.3390/ijms27219842}
}
Kostenlos starten →